IL141348A0 - Transdermally delivered aspirin - Google Patents
Transdermally delivered aspirinInfo
- Publication number
- IL141348A0 IL141348A0 IL14134899A IL14134899A IL141348A0 IL 141348 A0 IL141348 A0 IL 141348A0 IL 14134899 A IL14134899 A IL 14134899A IL 14134899 A IL14134899 A IL 14134899A IL 141348 A0 IL141348 A0 IL 141348A0
- Authority
- IL
- Israel
- Prior art keywords
- aspirin
- transdermally delivered
- transdermally
- delivered
- delivered aspirin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32934999A | 1999-06-10 | 1999-06-10 | |
PCT/US1999/012793 WO2000076315A1 (en) | 1999-06-10 | 1999-06-11 | Transdermally delivered aspirin |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141348A0 true IL141348A0 (en) | 2002-03-10 |
Family
ID=23284975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14134899A IL141348A0 (en) | 1999-06-10 | 1999-06-11 | Transdermally delivered aspirin |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1104236A1 (en) |
JP (1) | JP2003501447A (en) |
KR (1) | KR20010072412A (en) |
AU (1) | AU4552399A (en) |
BR (1) | BR9912954A (en) |
CA (1) | CA2340120A1 (en) |
HU (1) | HUP0103110A3 (en) |
IL (1) | IL141348A0 (en) |
MX (1) | MXPA01001490A (en) |
TR (1) | TR200100452T1 (en) |
WO (1) | WO2000076315A1 (en) |
ZA (1) | ZA200101153B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103528D0 (en) | 2001-10-21 | 2001-10-21 | Jan Faergeman | Topical compositions with enhanced effect |
WO2011076401A1 (en) | 2009-12-23 | 2011-06-30 | Holger Schankin | Substantially water-free pharmaceutical compositions containing acetylsalicylic acid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4725590A (en) * | 1983-08-24 | 1988-02-16 | Lever Brothers Company | Method of relieving pain and inflammatory conditions employing substituted salicylamides |
-
1999
- 1999-06-11 CA CA002340120A patent/CA2340120A1/en not_active Abandoned
- 1999-06-11 IL IL14134899A patent/IL141348A0/en unknown
- 1999-06-11 KR KR1020017001792A patent/KR20010072412A/en not_active Application Discontinuation
- 1999-06-11 EP EP99928460A patent/EP1104236A1/en not_active Withdrawn
- 1999-06-11 HU HU0103110A patent/HUP0103110A3/en unknown
- 1999-06-11 WO PCT/US1999/012793 patent/WO2000076315A1/en not_active Application Discontinuation
- 1999-06-11 JP JP2001502672A patent/JP2003501447A/en active Pending
- 1999-06-11 BR BR9912954-0A patent/BR9912954A/en not_active Application Discontinuation
- 1999-06-11 AU AU45523/99A patent/AU4552399A/en not_active Abandoned
- 1999-06-11 TR TR2001/00452T patent/TR200100452T1/en unknown
- 1999-06-11 MX MXPA01001490A patent/MXPA01001490A/en unknown
-
2001
- 2001-02-09 ZA ZA200101153A patent/ZA200101153B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2340120A1 (en) | 2000-12-21 |
WO2000076315A1 (en) | 2000-12-21 |
BR9912954A (en) | 2001-05-08 |
KR20010072412A (en) | 2001-07-31 |
TR200100452T1 (en) | 2001-07-23 |
EP1104236A1 (en) | 2001-06-06 |
HUP0103110A2 (en) | 2002-05-29 |
ZA200101153B (en) | 2002-05-09 |
HUP0103110A3 (en) | 2002-11-28 |
MXPA01001490A (en) | 2002-11-29 |
AU4552399A (en) | 2001-01-02 |
JP2003501447A (en) | 2003-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200316A1 (en) | Therapeutic microfoams | |
GB9911863D0 (en) | Therapeutic agents | |
GB9905010D0 (en) | Therapeutic agents | |
GB9904786D0 (en) | Therapeutic agents | |
GB9930570D0 (en) | Therapy | |
EG23858A (en) | Drug combination | |
GB9911881D0 (en) | Therapeutic agents | |
GB9907243D0 (en) | Therapy | |
GB9930079D0 (en) | Medicaments | |
GB9930071D0 (en) | Medicaments | |
GB9911802D0 (en) | Therapeutic combination | |
GB9903476D0 (en) | Therapeutic agents | |
EP1150700A4 (en) | Antiangiogenic drugs | |
GB9911803D0 (en) | Therapeutic combination | |
GB9911804D0 (en) | Therapeutic combination | |
GB9903119D0 (en) | Therapeutic agents | |
GB9914742D0 (en) | Therapeutic agents | |
GB9930083D0 (en) | Medicaments | |
GB9924990D0 (en) | Medicaments | |
GB9902881D0 (en) | Therapeutic agents | |
IL141348A0 (en) | Transdermally delivered aspirin | |
GB9930082D0 (en) | Medicaments | |
GB9929040D0 (en) | Medicaments | |
GB9914743D0 (en) | Therapeutic agents | |
CZ2001512A3 (en) | Transdermally administered aspirin |